Literature DB >> 9379069

Transdermal fentanyl as treatment for chronic low back pain.

R K Simpson1, E A Edmondson, C F Constant, C Collier.   

Abstract

Management of chronic low back pain often includes oral opioid use. The effectiveness of therapy is dependent upon compliance, which in turn is dependent upon response, side effects, access, and convenience. Our hypothesis was that a transdermal fentanyl system would provide more effective pain management than oral opioids. Fifty patients with chronic low back pain were examined. After litration to levels corresponding to current oral opioid use, each patient was maintained on transdermal fentanyl for one month. Oral opioid therapy was then resumed. Their experience was assessed with the a visual analogue scale for pain intensity, a numerical pain score, the Oswestry disability questionnaire, the pain disability index, and the Verran Snyder-Halpern sleep scale. Significant improvement in pain relief and disability was found with transdermal fentanyl compared with oral opioids. Mild opioid side effects were common, but easily controlled. Use of transdermal fentanyl is an effective alternative to oral opioids for managing chronic low back pain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379069     DOI: 10.1016/s0885-3924(97)00183-8

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  16 in total

1.  [Effective pain relief facilitates exercise therapy : Results of a multicenter study with controlled-release oxycodone in patients with movement pain].

Authors:  W Teske; A Anastasiadis; J Krämer; T Theodoridis
Journal:  Orthopade       Date:  2008-12       Impact factor: 1.087

2.  Opioids in chronic musculoskeletal conditions.

Authors:  Jaime Calvo-Alén
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-10       Impact factor: 5.346

3.  Awake Blind Nasotracheal Intubation in Temporomandibular Joint Ankylosis Patients under Conscious Sedation Using Fentanyl and Midazolam.

Authors:  Satish Dhasmana; Vibha Singh; U S Pal
Journal:  J Maxillofac Oral Surg       Date:  2011-03-17

Review 4.  Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.

Authors:  S Grond; L Radbruch; K A Lehmann
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

5.  Transdermal fentanyl for the treatment of pain caused by rheumatoid arthritis.

Authors:  Gabriel Herrero-Beaumont; Olav Bjorneboe; Ute Richarz
Journal:  Rheumatol Int       Date:  2004-10-05       Impact factor: 2.631

Review 6.  Pharmacotherapy of neuropathic low back pain.

Authors:  Michael H Moskowitz
Journal:  Curr Pain Headache Rep       Date:  2003-06

7.  Transdermal fentanyl improves pain control and functionality in patients with osteoarthritis: an open-label Canadian trial.

Authors:  Denis Choquette; Timothy G McCarthy; Jude F N Rodrigues; Allan J Kelly; Fernando Camacho; G L A Horbay; Farah A Husein-Bhabha
Journal:  Clin Rheumatol       Date:  2007-11-23       Impact factor: 2.980

8.  Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: a placebo-controlled, randomized study.

Authors:  C Cloutier; John Taliano; W O'Mahony; M Csanadi; G Cohen; I Sutton; D Sinclair; M Awde; S Henein; L Robinson; J Eisenhoffer; P S Piraino; Z Harsanyi; K J Michalko
Journal:  Pain Res Manag       Date:  2013 Mar-Apr       Impact factor: 3.037

9.  Validation of a French-Canadian version of the Pain Disability Index.

Authors:  Nathalie Gauthier; Pascal Thibault; Heather Adams; Michael J L Sullivan
Journal:  Pain Res Manag       Date:  2008 Jul-Aug       Impact factor: 3.037

Review 10.  Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain.

Authors:  J Devulder; A Jacobs; U Richarz; H Wiggett
Journal:  Br J Anaesth       Date:  2009-09-06       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.